Exponent (EXPO) Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" EXPO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXPO, but not buy additional shares or sell existing shares.
View EXPO analyst ratings or view top-rated stocks.

3 brokerages have issued 12 month price objectives for Exponent's shares. Their EXPO share price forecasts range from $99.00 to $110.00. On average, they expect the company's share price to reach $104.50 in the next year. This suggests a possible upside of 21.0% from the stock's current price.
View analysts price targets for EXPO or view top-rated stocks among Wall Street analysts.

Exponent's stock was trading at $99.09 at the start of the year. Since then, EXPO stock has decreased by 12.9% and is now trading at $86.33.
View the best growth stocks for 2023 here.

Exponent saw a decrease in short interest in August. As of August 31st, there was short interest totaling 1,060,000 shares, a decrease of 10.2% from the August 15th total of 1,180,000 shares. Based on an average daily trading volume, of 224,100 shares, the days-to-cover ratio is presently 4.7 days. Approximately 2.1% of the company's shares are sold short.
View Exponent's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our EXPO earnings forecast.

Exponent, Inc. (NASDAQ:EXPO) announced its quarterly earnings results on Thursday, July, 27th. The business services provider reported $0.50 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.51 by $0.01. The business services provider had revenue of $129.65 million for the quarter, compared to analyst estimates of $130.40 million. Exponent had a trailing twelve-month return on equity of 30.41% and a net margin of 19.03%. The firm's revenue was up 9.7% on a year-over-year basis. During the same period last year, the business earned $0.49 EPS.

Exponent announced a quarterly dividend on Tuesday, July 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.26 per share on Friday, September 22nd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for EXPO.

ETFs with the largest weight of Exponent (NASDAQ:EXPO) stock in their portfolio include iShares Emergent Food and AgTech Multisector ETF (IVEG), Argent Mid Cap ETF (AMID), Hypatia Women CEO ETF (WCEO), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF Shares (OUSM), Franklin U.S. Small Cap Multifactor Index ETF (FLQS), Vident Core U.S. Equity Fund (VUSE) and iShares Russell 2000 Growth ETF (IWO).

Exponent (NASDAQ:EXPO) pays an annual dividend of $1.04 per share and currently has a dividend yield of 1.21%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 52.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 46.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

Exponent shares split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were issued to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Exponent's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.83%), Kayne Anderson Rudnick Investment Management LLC (8.41%), Conestoga Capital Advisors LLC (4.75%), State Street Corp (3.33%), Geneva Capital Management LLC (2.78%) and Geode Capital Management LLC (2.32%). Insiders that own company stock include Bradley A James, Carol Lindstrom, George H Brown, Harri Kytomaa, John Pye, Joseph Rakow, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends.

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EXPO stock can currently be purchased for approximately $86.33.

Exponent (NASDAQ:EXPO) has a market capitalization of $4.39 billion and generates $513.29 million in revenue each year. The business services provider earns $102.33 million in net income (profit) each year or $1.97 on an earnings per share basis.

The company employs 1,313 workers across the globe.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.